# Hospira, Inc., Rocky Mount, NC – FDA Inspections

Source: https://www.keypedia.com/companies/hospira-inc/d4decc1e-4b42-43bb-be2c-abcefbc7b965

> Inspection records and compliance data for Hospira, Inc. in Rocky Mount, North Carolina. 13 FDA inspections on record (5 OAI), 2 Form 483s, 1 warning letter, last inspected February 07, 2025.

---

## Details

- Name: Hospira, Inc.
- FEI Number: 1021343
- Facility Type: Pharmaceutical and Device Manufacturer / Gamma Irradiator
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE
- Address Line 1: 4285 N Wesleyan Blvd
- City: Rocky Mount
- State: North Carolina
- Zip Code: 27804
- Country Name: United States
- Address: 4285 N Wesleyan Blvd, Rocky Mount, North Carolina 27804, United States
- Country: United States

## Related Documents

- FDA Inspection 1251941 - Hospira, Inc. - 2025-02-07 — source: FDA, date: February 7, 2025
- FDA Inspection 1251941 - Hospira, Inc. - 2025-02-07 — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2025
- [483 - Hospira, Inc. - 2023-11-14](https://www.keypedia.com/records/483/hospira-inc/5c3e063a-836d-4935-b609-0dea69d3e704) — source: FDA, date: November 14, 2023
- [FDA Inspection 1223090 - Hospira, Inc. - 2023-11-14](https://www.keypedia.com/records/fda_inspections/hospira-inc/f035aae9-e0b2-49a1-a514-e54edbf04704) — classification: Official Action Indicated (OAI), source: FDA, date: November 14, 2023
- [483 - Hospira, Inc. - 2019-11-21](https://www.keypedia.com/records/483/hospira-inc/e86d25f7-dbfb-46b3-a9cc-424f1d165750) — source: FDA, date: November 21, 2019
- [FDA Inspection 1110899 - Hospira, Inc. - 2019-11-21](https://www.keypedia.com/records/fda_inspections/hospira-inc/8bc1ca51-7f35-4184-ac20-80876c3d27fd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 21, 2019
- [483 - Hospira, Inc. - 2018-02-02](https://www.keypedia.com/records/483/hospira-inc/fe237d3b-7ac6-4cc0-a546-a4c2899ac024) — source: FDA, date: February 2, 2018
- FDA Inspection 1039547 - Hospira, Inc. - 2018-02-02 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 2, 2018
- [FDA Inspection 1039547 - Hospira, Inc. - 2018-02-02](https://www.keypedia.com/records/fda_inspections/hospira-inc/ff0a477b-a209-46bc-a7b5-cd6391330701) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 2, 2018
- FDA Inspection 984874 - Hospira, Inc. - 2016-05-26 — classification: No Action Indicated (NAI), source: FDA, date: May 26, 2016
- FDA Inspection 942202 - Hospira, Inc. - 2015-09-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2015
- FDA Inspection 942202 - Hospira, Inc. - 2015-09-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2015
- FDA Inspection 942202 - Hospira, Inc. - 2015-09-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2015
- [WARNING_LETTER - Hospira, Inc. - 2013-11-15](https://www.keypedia.com/records/warning_letter/hospira-inc/e87a2420-2ae9-450b-ba61-65d3dbff6f23) — source: FDA, date: November 15, 2013
- [483 - Hospira, Inc. - 2013-03-01](https://www.keypedia.com/records/483/hospira-inc/b0545b4f-6e65-4d0b-8823-a90867a7bedf) — source: FDA, date: March 1, 2013
- [483 - Hospira, Inc. - 2012-10-24](https://www.keypedia.com/records/483/hospira-inc/99e29fe1-698d-4c85-a456-eaabb6e76e7a) — source: FDA, date: October 24, 2012
- [483 - Hospira, Inc. - 2012-07-26](https://www.keypedia.com/records/483/hospira-inc/ecb9d0a0-1284-4b8c-89ac-f3ce4b72c2cb) — source: FDA, date: July 26, 2012
- [483 - Hospira, Inc. - 2011-08-04](https://www.keypedia.com/records/483/hospira-inc/985730f5-cef4-479b-8ac8-0e7241142062) — source: FDA, date: August 4, 2011
- [483 - Hospira, Inc. - 2011-06-17](https://www.keypedia.com/records/483/hospira-inc/82896c82-4b42-450b-bb14-c9eb1b79cac1) — source: FDA, date: June 17, 2011
- [EIR - Hospira, Inc. - 2010-01-19](https://www.keypedia.com/records/eir/hospira-inc/6fc2dda5-a6de-4424-bcde-b0a650347cc3) — source: FDA, date: January 19, 2010

## Related Companies

- [Medical Products Laboratories, Inc.](https://www.keypedia.com/companies/medical-products-laboratories-inc/7e417525-325c-4b38-9007-cee432ed2387)
- [Aphena Pharma Solutions-Maryland LLC](https://www.keypedia.com/companies/aphena-pharma-solutions-maryland-llc/97893fd6-3370-41f2-95ce-17928ab057e2)
- [Quality Packaging Specialists International, LLC](https://www.keypedia.com/companies/quality-packaging-specialists-international-llc/74a9861b-efac-463e-b6f9-bd1e22db674a)
- [Chartwell Pharmaceuticals Carmel LLC](https://www.keypedia.com/companies/chartwell-pharmaceuticals-carmel-llc/7d10681a-1557-4f23-bde4-a9fad718e27f)
- [Almac Pharma Services LLC](https://www.keypedia.com/companies/almac-pharma-services-llc/a5015855-2f01-4474-895d-a397cc89e5fa)
- [The Procter & Gamble Manufacturing Company](https://www.keypedia.com/companies/the-procter-gamble-manufacturing-company/ceebac3f-c234-4225-b666-964153cdba97)
- [Sovereign Pharmaceuticals, LLC](https://www.keypedia.com/companies/sovereign-pharmaceuticals-llc/b8432227-cad1-4c55-91cc-a8c613f765fd)
- [Lannett Company LLC](https://www.keypedia.com/companies/lannett-company-llc/d4d7f04f-0ec5-4f5a-868b-d48963202cc8)
- [Accupac, Llc](https://www.keypedia.com/companies/accupac-llc/f9c2fbfc-4f22-433c-8e1c-bde11182952f)
- [BioRamo, LLC](https://www.keypedia.com/companies/bioramo-llc/c32084c1-7762-45e7-aff6-b09ea6dfdf17)

## Related Officers

- [Program Expert](https://www.keypedia.com/people/thomas-r-berry/d162384e-0291-4ae8-bce1-564dafd4d798)
- [Site Quality Director](https://www.keypedia.com/people/hector-e-jimenez/c1f2226a-36a2-428f-91e8-49758cf27467)
- [Chemist](https://www.keypedia.com/people/daphne-santiago/8d875abe-9ff5-408d-addf-6d07d07767cf)
- [Penny H. McCarver](https://www.keypedia.com/people/penny-h-mccarver/d67e1e77-b311-440c-9537-0746284c1368)
